Aclaris Therapeutics (NASDAQ:ACRS) Rating Increased to Overweight at Cantor Fitzgerald
Aclaris Therapeutics (NASDAQ:ACRS – Get Free Report) was upgraded by Cantor Fitzgerald from a “neutral” rating to an “overweight” rating in a research report issued on Wednesday,Briefing.com Automated Import reports. A number of other research firms have also issued reports on ACRS. StockNews.com raised shares of Aclaris Therapeutics from a “sell” rating to a “hold” […]
More Stories
VanEck Morningstar Wide Moat Value ETF (NYSEARCA:MVAL) Announces $0.31 Dividend
VanEck Morningstar Wide Moat Value ETF (NYSEARCA:MVAL – Get Free Report) declared a dividend on Friday, December 20th,NASDAQ Dividends reports....
First Bancshares Inc. (Bellevue, OH) Declares Quarterly Dividend of $0.33 (OTCMKTS:FIBH)
First Bancshares Inc. (Bellevue, OH) (OTCMKTS:FIBH – Get Free Report) declared a quarterly dividend on Thursday, December 19th,NASDAQ Dividends reports....
Invesco AAA CLO Floating Rate Note ETF to Issue Dividend of $0.11 (BATS:ICLO)
Invesco AAA CLO Floating Rate Note ETF (BATS:ICLO – Get Free Report) announced a dividend on Friday, December 20th,NASDAQ Dividends...
Falcon Gold (CVE:FG) Trading Up 25% – Should You Buy?
Shares of Falcon Gold Corp. (CVE:FG – Get Free Report) traded up 25% on Saturday . The company traded as...
Elderberry: The Immunity Defender That Helps You Fight Cold and Flu
By Sena McCullough Elderberry has been revered for centuries as a go-to remedy for respiratory infections, fever, and inflammation—both acute...
Goldman Sachs ETF Trust Goldman (GPOW) To Go Ex-Dividend on December 23rd
Goldman Sachs ETF Trust Goldman (NYSEARCA:GPOW – Get Free Report) declared a dividend on Friday, December 20th,NASDAQ Dividends reports. Shareholders...